Streptococcal Tonsillitis — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for streptococcal tonsillitis. 15 active patents protecting 2 drugs from 1+ originators. First major cliff: 2028. Daily refresh.

2
Approved drugs
15
Active US patents
67/100
Avg vulnerability
—
Annual revenue covered

Originators in Streptococcal Tonsillitis

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Beecham/GSK) 14 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating streptococcal tonsillitis. Each bar = one year. Y-axis scaled to peak year (6 patents).

2
26
1
27
1
28
4
30
6
34

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Amoxil
amoxicillin
 Generic (originally Beecham/GSK) 14 58 — 2026-12-08
Suprax
CEFIXIME
 — 1 75 — 2028-12-14

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8299052 Amoxil method of use 85 2027-05-07
8778924 Amoxil method of use 80 2026-12-08
9233112 Suprax method of use 75 2028-12-14
11931463 Amoxil method of use 75 2034-02-12
11878011 Amoxil method of use 75 2042-05-27
8357394 Amoxil formulation 65 2026-12-08
9498445 Amoxil method of use 62 2034-02-12
11135172 Amoxil method of use 62 2034-02-12
9603806 Amoxil method of use 62 2034-02-12
9050263 Amoxil method of use 62 2034-02-12

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
7977488 Amoxil composition of matter 18 2030-04-10
7977488 Amoxil composition of matter 18 2030-04-10
10238606 Amoxil formulation 42 2034-02-12
9186411 Amoxil formulation 56 2030-08-11
9186411 Amoxil formulation 56 2030-08-11
9050263 Amoxil method of use 62 2034-02-12
11135172 Amoxil method of use 62 2034-02-12
9603806 Amoxil method of use 62 2034-02-12
9498445 Amoxil method of use 62 2034-02-12
8357394 Amoxil formulation 65 2026-12-08

Related